Virus Diseases: all 927 studies
Page 5 of 10. Open to participants first (112), then studies with results posted, then the rest; newest registration first within each.
- Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)SuspendedNCT05387278Phase 1
- Electronic Medical Records to Increase Adherence to the Choosing Wisely RecommendationsCompletedNCT05385445Not applicable
- Rituximab Monotherapy for EBV-HLH and CAEBVStatus unknownNCT05384743Phase 3
- The Effects of Video-based Yoga Interventions for Patients With Post-corona Virus DiseaseCompletedNCT05374668Not applicable
- Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical ValidationCompletedNCT05364268
- Tobacco Use and the Risk of COVID-19 and Adverse OutcomesCompletedNCT05321433
- Integrating Enhanced HIV PrEP Into a STI Clinic in LilongweCompletedNCT05307991
- Assessment of the Efficacy of Calcium Dobesilate vs. Placebo on SARS-CoV-2 Viral Load Amongst Outpatients With COVID-19.CompletedNCT05305508Phase 2
- West Nile Virus Seroprevalence Under Bird RingersCompletedNCT05294003
- Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone StudyCompletedNCT05284097Phase 2
- The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella VaccineStatus unknownNCT05279248Phase 4
- STS Administration on Coronavirus Disease (COVID-19) Patients in Critical CareStatus unknownNCT05277285Phase 2
- Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral InfectionCompletedNCT05273619Phase 3
- Efficacy and Safety of XC8, Film-coated Tablets, 10 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral InfectionCompletedNCT05269329Phase 2
- Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral InfectionsCompletedNCT05269290Phase 3
- Covid-19 Vaccine Response in Heart Transplant RecipientsCompletedNCT05268679
- Cytopenias in Hospitalized Patients of Corona Virus Infection(COVID-19) During First and Other WavesCompletedNCT05258812
- REVIVe: Frailty, Rehabilitation, and Outcomes in Critically Ill Adult and Pediatric Survivors of COVID-19 or ARICompletedNCT05246098
- A Study of Cetrelimab in Participants With Chronic Hepatitis B Virus InfectionCompletedNCT05242445Phase 1
- A Study of Safety and Efficacy of ATI-2173 and Vebicorvir in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus InfectionTerminatedNCT05238844Phase 2
- Prognostic Significance of COVID-19 MSCT Chest Findings on Short Term Disease ProgressionCompletedNCT05235373
- Influenza and Pertussis Vaccination Status of Women in Immediate Postpartum and CaregiversCompletedNCT05234229
- Host RNA Expression Profiles and Protein Biomarkers in Neonatal Herpes Simplex Virus InfectionCompletedNCT05226949
- HIV Indicator Diseases in Hospital and Primary CareStatus unknownNCT05225493
- Evaluation of the Efficacy and Safety of Zinc in Viral InfectionsCompletedNCT05212480Not applicable
- The Impact of the Previous Exposure to Covid-19 Virus Infection on the Outcome of ICSI CyclesCompletedNCT05198401
- Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical StudyStatus unknownNCT05180851Early Phase 1
- Health Belief Model Based Education on Human Papilloma Virus Infection and VaccinationCompletedNCT05175482Not applicable
- Clinical Trial for Oral Formula of Vanillin and Wheat Germ Oil for Treatment of Mild and Moderate COVID-19 Viral DiseaseStatus unknownNCT05157139Phase 2/3
- Adjuvant Use Of Colchicine With The Standard Therapy In Moderate And Severe Corona Virus Disease-19 InfectionCompletedNCT05151614Phase 1
- Safety and Immunogenicity of the rVSVΔG-ZEBOV-GP Ebola Virus Vaccine Candidate in Children Living in Lambaréné, GabonCompletedNCT05130398Phase 1/2
- A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus InfectionCompletedNCT05123599Phase 1
- Analytical Performances and Clinical Impact of the Roche Cobas® Liat Influenza A/B & RSV Assay in the Management of Adult and Pediatric Patients Attending the Emergency RoomTerminatedNCT05105191Not applicable
- Evaluation of the Detection Performance of the N Antigenemia of SARS-CoV-2 in the General Population for the Diagnosis and Screening of COVID-19Status unknownNCT05092607Not applicable
- Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) for Patients With Hepatitis C Virus InfectionStatus unknownNCT05092074
- Implementation of Academic Detailing Interventions on Prescribing of Antimicrobial Drugs in Primary Health CareCompletedNCT05090475Not applicable
- Micro-hematology Analyzer for Viral/Bacterial DescriptionStatus unknownNCT05090319
- Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)WithdrawnNCT05085574Phase 2
- A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of AgeTerminatedNCT05085366Phase 3
- Preventing Respiratory Viral Illness InvisiblyCompletedNCT05084898Not applicable
- HPV and Male Homosexuality in General Practice?CompletedNCT05078554
- Post-COVID-19 Monitoring in Routine Health Insurance DataCompletedNCT05074953
- A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult VolunteersCompletedNCT05069623Phase 1/2
- Ad26.ZEBOV Booster in HIV+ Adults Previously Vaccinated With Ad26.ZEBOV/MVA-BN-Filo (EBOVAC HIV+ Booster Study)CompletedNCT05064956Phase 2
- TTV Viral Load in Heart Transplant RecipientsCompletedNCT05064462
- RNA Sequencing of Individual Versus Wastewater - SARS-CoV2CompletedNCT05041764
- Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19CompletedNCT05037162Phase 2
- Azithromycin Plus Hydroxychloroquine for COVID-19 InfectionWithdrawnNCT05026801Phase 3
- Targeting de Novo Pyrimidine Biosynthesis by Leflunomide for the Treatment of COVID-19 Virus DiseaseCompletedNCT05007678Phase 3
- Echinaforce Study to Investigate Explorative Pharmacology and Effectiveness to Prevent From Enveloped Virus InfectionsCompletedNCT05002179Phase 4
- An Effectiveness Trial to Evaluate Protection of Children and Pregnant Women by Influenza Vaccine in Rural BangladeshActive, not recruitingNCT04998344Phase 4
- Evaluation of the Effectiveness of Therapy for Patients With Covid-19 Using Food Supplements Viusid + AsbripCompletedNCT04980534Not applicable
- A Long-Term Extension Study to Evaluate the Immunogenicity and Safety of Cytomegalovirus (CMV) mRNA-1647 VaccineCompletedNCT04975893Phase 2
- A 2 PART STUDY EVALUATING EDP-721 IN HEALTHY SUBJECTS AND EDP-721 IN COMBINATION WITH EDP-514 IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION.TerminatedNCT04971512Phase 1
- Safety and Immunogenicity of VLA2001 Adults Aged ≥56 YearsCompletedNCT04956224Phase 3
- Can COVID-19 Persist in Intraocular Fluid?CompletedNCT04945850
- Study to Evaluate the Safety and Concentrations of Monoclonal Antibody Against Virus That Causes COVID-19 Disease.CompletedNCT04932850Phase 1
- Natural History Study of COVID-19 Using Digital WearablesCompletedNCT04927442
- Infection With Respiratory Syncytial Virus in InfantsStatus unknownNCT04925310
- COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults - Impact of Variants (Dyn3CEA - Nosocor Phase 2)CompletedNCT04924842
- Study of VN-0200 in Japanese Healthy Adults and Elderly SubjectsCompletedNCT04914520Phase 1
- Consequences of a Maternal-fetal Chikungunya Virus InfectionCompletedNCT04909411Not applicable
- Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seronegative Children 6-36 MonthsStatus unknownNCT04909021Phase 1
- INO-4201 as Booster in Healthy VSV-ZEBOV VaccineesCompletedNCT04906629Phase 1
- The Evaluation of Cellular and Humoral Immunity to COVID-19 in Moscow ResidentsCompletedNCT04898140
- Efficacy and Safety of Longan Extract Spray (P80 Spray) in Volunteers With Coronavirus Disease 2019 (COVID-19)Status unknownNCT04887233Not applicable
- A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019（COVID-19）PneumoniaCompletedNCT04880694Phase 2
- COV-COMPARE Immunogenicity of Vaccine VLA2001 Compared to AZD1222CompletedNCT04864561Phase 3
- A Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection and in Subjects With Hepatitis D Virus CoinfectionTerminatedNCT04847440Phase 2
- PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT)WithdrawnNCT04842331Phase 2/3
- Host RNA Profiles to Detect Infections in Young InfantsCompletedNCT04823026
- EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19CompletedNCT04822818Phase 3
- Prophylaxis Vaccine Antibodies EbolaStatus unknownNCT04822376Phase 2
- Observational Study of the Clinico-biological Evolution and Standard of Care Offered to Patients With Ebola Virus DiseaseCompletedNCT04815174
- Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19Status unknownNCT04802382Phase 3
- Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 PatientsCompletedNCT04793984Not applicable
- Effect of N-acetylcysteine on Oxidative Stress in COVID-19 PatientsCompletedNCT04792021Phase 3
- COVID-19 Infections and Mortality in Long-term Care Facilities During the First WaveCompletedNCT04782427
- The Role of Lactate in Viral and Bacterial InfectionCompletedNCT04777747
- Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and DiabetesCompletedNCT04769167Not applicable
- HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral TherapyStatus unknownNCT04768517
- Does Hepatitis C Management Protect Egyptian Population Against Severe Corona Virus Disease-2019?CompletedNCT04757272
- Comparison of Chest CT Findings Related to COVID-19 With RSNA and BSTI GuidelinesCompletedNCT04754633
- Multimodal IMAgery Characterization of Cardiac Damage and Severity After COVID-19 InfectionCompletedNCT04753762
- Assess the Correlation With Severe Respiratory Syncytial Virus Disease in the First 6 Months in Children With Congenital Heart Disease and Maternal Ac-AntiVSR Titers During PregnancyStatus unknownNCT04734782
- HCV Reinfection in HD Patients Achieving SVRStatus unknownNCT04732832
- Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy AdultsCompletedNCT04723602Phase 1
- An Open Study of the Safety and Pharmacokinetics of a Drug for the Emergency Prevention of Ebola Virus DiseaseStatus unknownNCT04717830Phase 1
- Oral and Perioral Herpes Simplex Virus Infection Type I in a Five-month-old Infant: A Case ReportCompletedNCT04713423
- Trial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19)CompletedNCT04710199Phase 2
- To Evaluate the Efficacy and Safety of TG-1000 Compared With Placebo in Adult Patients With Acute Uncomplicated Influenza Virus InfectionCompletedNCT04706468Phase 2
- Assessment of the Clinical Effectiveness of a Herbal Extract (Cretan IAMA) in Patients With Viral Respiratory Infections, Including COVID-19, in Primary Healthcare Settings, and Co-assessment of Its Prophylactic Effect in People Cohabiting With These PatientsCompletedNCT04705753Phase 2/3
- Theranostic Implication of Complementary Medicines Against Interleukin Receptors and Gp-130 ProteinsCompletedNCT04690920Not applicable
- Establish MeMed BV™ Performance for Differentiating Bacterial From Viral Infection in Suspected Acute Infection Patients (APOLLO STUDY)CompletedNCT04690569
- PROtocol for Coxsackievirus VaccinE in Healthy VoluNTteersCompletedNCT04690426Phase 1
- Use of Hypochlorous Acid as Prophylaxis in Health Personnel at High Risk of Infection by SARS-CoV 2 (COVID19)WithdrawnNCT04684550Phase 2/3
- Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care WorkersCompletedNCT04681001Not applicable
- Prevalence of Occult Hepatitis B Virus Infection（OBI） in Subjects With Chronic Hepatitis B（CHB） Family HistoryStatus unknownNCT04672915
- COVID-19 Neurological Disease: A Prospective StudyCompletedNCT04672590
- Morbidity and Mortality of Hepatitis E Virus Infections in BelgiumCompletedNCT04670419